SPONSOR
King Faisal Specialist Hospital & Research Center
Total Trials
2
Recruiting
2
Phases
Phase 3
Conditions studied: Acute Lymphoblastic Leukemia (ALL) in Complete RemissionAcute Myeloid Leukemia (AML) in RemissionAsthma Childhood
King Faisal Specialist Hospital & Research Center is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Acute Lymphoblastic Leukemia (ALL) in Complete Remission, Acute Myeloid Leukemia (AML) in Remission, Asthma Childhood.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — King Faisal Specialist Hospital & Research Center
How many clinical trials has King Faisal Specialist Hospital & Research Center sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by King Faisal Specialist Hospital & Research Center, of which 2 are actively recruiting participants. These trials cover conditions including Acute Lymphoblastic Leukemia (ALL) in Complete Remission, Acute Myeloid Leukemia (AML) in Remission, Asthma Childhood. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does King Faisal Specialist Hospital & Research Center research focus on?
King Faisal Specialist Hospital & Research Center clinical trials span Acute Lymphoblastic Leukemia (ALL) in Complete Remission, Acute Myeloid Leukemia (AML) in Remission, Asthma Childhood. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a King Faisal Specialist Hospital & Research Center clinical trial?
To participate in a King Faisal Specialist Hospital & Research Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all King Faisal Specialist Hospital & Research Center trials with current recruitment status updated daily.
Clinical Trials by King Faisal Specialist Hospital & Research Center
NCT04314219 Phase 3
Recruiting
Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients
Acute Lymphoblastic Leukemia (ALL) in Complete Remission
NCT07788534
Recruiting
This Study Aims to Compare Asthma Control in Children Monitored With FeNO Against a Historical Cohort Without FeNO. Secondary Objectives Include Evaluating Associations Between FeNO Levels, ACT/C-ACT Scores, Eosinophil Counts, FEV1%, ICS Adherence, and Exacerbation Frequency.
Asthma Childhood
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology